The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Intratumoral microvessel density and L53 protein: Correlation with metastasis in head‐and‐neck squamous‐cell carcinoma
Abstract
Squamous‐cell carcinoma of the head and neck includes a heterogeneous group of tumours of the upper air and food passages for which prognosis is difficult to assess. In fact, patients in comparable stages may have diverse clinical courses and responses to similar treatments. In order to better define the prognosis of each patient there is therefore a need to identify novel biological markers which reflect more accurately growth rate, progression and metastatic potential of each tumour. We assessed whether metastases correlate with micro‐vessel counts (i.e. intratumoral vascularity) using the CD‐31 monoclonal antibody (MAb) and p53 mutant protein expression, determined in the primary by immunocytochemical methods in 70 patients with locally advanced head and neck cancer. Patients were treated with concurrent chemo‐radiotherapy; 50 of these presented loco‐regional node metastasis at diagnosis whereas 3 cases, initially node‐negative, developed distant metastasis during the period of observation. No feature was predictive for objective response to treatment. The overall mean and median blood vessel density at “hot spots” was 37.42 and 36, respectively, and 57% of the tumours expressed p53 mutant proteins. These 2 biological markers were significantly associated. Patients with metastases (loco‐regional and distant) had a significantly higher mean blood‐vessel density than those without tumour spread. Also, patients with p53‐positive (+/ + +) tumours had a significantly higher incidence of metastasis than those with negative ones. Multivariate analysis showed that both vascularity and stage, but not p53 expression, are significant and independent predictors of metastasis in this series.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Folkman, J., & Klagsbrun, M. (1987) · Science · doi:10.1126/science.2432664 · Cited by 3,491
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,733
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,654
Vokes, E. E., Weichselbaum, R. R., Lippman, S. M., & Hong, W. K. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280306 · Cited by 2,211
Induction of angiogenesis during the transition from hyperplasia to neoplasia
Folkman, J., Watson, K., Ingber, D., & Hanahan, D. (1989) · Nature · doi:10.1038/339058a0 · Cited by 1,879
Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., & Gasparini, G. (1992) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/84.24.1875 · Cited by 1,775
Self-citationTumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
Weidner, N., Carroll, P. R., Flax, J. D., Blumenfeld, W., & Folkman, J. (1993) · PubMed Central · Cited by 1,620
Self-citationSynthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., & Folkman, J. (1990) · Nature · doi:10.1038/348555a0 · Cited by 1,299
Ausprunk, D. H., & Folkman, J. (1977) · Microvascular Research · doi:10.1016/0026-2862(77)90141-8 · Cited by 1,281
Horak, E. R., Klenk, N., Leek, R., LeJeune, S., Smith, K., Stuart, N., Harris, A. L., Greenall, M., & Stepniewska, K. (1992) · The Lancet · doi:10.1016/0140-6736(92)93150-l · Cited by 800
Relation of neovascularisation to metastasis of non-small-cell lung cancer
Macchiarini, P., Fontanini, G., Squartini, F., Angeletti, C. A., & Hardin, M. J. (1992) · The Lancet · doi:10.1016/0140-6736(92)93217-b · Cited by 764
Modulation of Activity of the Promoter of the Human MDR 1 Gene by Ras and p53
Chin, K.-V., Ueda, K., Pastan, I., & Gottesman, M. M. (1992) · Science · doi:10.1126/science.1346476 · Cited by 726
Microvessel quantitation and prognosis in invasive breast carcinoma
Bosari, S., Lee, A. K. C., DeLellis, R. A., Wiley, B. D., Heatley, G. J., & Silverman, M. L. (1992) · Human Pathology · doi:10.1016/0046-8177(92)90344-3 · Cited by 549
Srivastava, A., Laidler, P., Davies, R. P., Horgan, K. J., & Hughes, L. E. (1988) · PubMed Central · Cited by 528
Boring, C. C., Squires, T. S., & Tong, T. (1992) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.42.1.19 · Cited by 528
Genetic Mechanisms of Tumor Suppression by the Human p53 Gene
Chen, P.-L., Chen, Y., Bookstein, R., & Lee, W.-H. (1990) · Science · doi:10.1126/science.2274789 · Cited by 518
Wolf, D., Harris, N., & Rotter, V. (1984) · Cell · doi:10.1016/0092-8674(84)90532-4 · Cited by 249
Field, J., Spandidos, D., Malliri, A., Gosney, Jr., Yiagnisis, M., & Stell, P. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.352 · Cited by 247
Different Tumor-Derived p53 Mutants Exhibit Distinct Biological Activities
Halevy, O., Michalovitz, D., & Oren, M. (1990) · Science · doi:10.1126/science.2218501 · Cited by 234
Maestro, R., Dolcetti, R., Gasparotto, D., Doglioni, C., Pelucchi, S., Barzan, L., Grandi, E., & Boiocchi, M. (1992) · PubMed · Cited by 201
Gerwin, B. I., Spillare, E. A., Forrester, K., Lehman, T. A., Kispert, J., Welsh, J. A., Pfeifer, A. M. A., Lechner, J. F., Baker, S. J., & Vogelstein, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2759 · Cited by 131
Zastawny, R. L., Salvino, R., Chen, J., Benchimol, S., & Ling (1993) · PubMed · Cited by 118
Reiss, M., Vellucci, V. F., & Zhou, Z. (1993) · PubMed · Cited by 67
Hagemeier, H.-H., Vollmer, E., Goerdt, S., Schulze‐Osthoff, K., & Sorg, C. (1986) · International Journal of Cancer · doi:10.1002/ijc.2910380405 · Cited by 67
Cited by
Angiogenesis and Tumor Metastasis
Zetter, B. R. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.407 · Cited by 1,015
Weidner, N. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00666038 · Cited by 718
Self-citationIncreased angiogenesis in the bone marrow of patients with acute myeloid leukemia
Padró, T., Ruiz, S., Bieker, R., Bürger, H., Steins, M., Kienast, J., Büchner, T., Berdel, W. E., & Mesters, R. M. (2000) · Blood · doi:10.1182/blood.v95.8.2637 · Cited by 476
Gasparini, G., Weidner, N., Bevilacqua, P., Maluta, S., Dalla Palma, P., Caffo, O., Barbareschi, M., Boracchi, P., Marubini, E., & Pozza, F. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.454 · Cited by 464
Self-citationRole of nitric oxide in angiogenesis and tumor progression in head and neck cancer
Gallo, O., Fini-Storchi, I., Vergari, W. A., Masini, E., Morbidelli, L., Ziche, M., & Franchi, A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.8.587 · Cited by 427
Metadata
- Authors
- Gasparini, G., Weidner, N., Maluta, S., Pozza, F., Boracchi, P., Mezzetti, M., Testolin, A., & Bevilacqua, P.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1993-11-11
- Volume
- 55
- Issue
- 5
- Pages
- 739-744
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1994025908
- Cited by
- 305
- References
- 25
- FWCI
- 21.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.